We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Clears Lupin’s Mandideep Manufacturing Facility
FDA Clears Lupin’s Mandideep Manufacturing Facility
February 2, 2010
The FDA has sent Lupin Pharmaceuticals an official communication that the company resolved an earlier warning letter to its Mandideep, India, facility.